Pharmafile Logo
Pharmafocus logo
Advanced Search

neuroscience

Showing 12 posts of 27 posts found.

Pfizer pumps $600m into venture fund, targeting neuroscience

June 7, 2018
Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical

Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma

As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …

News
celgene_1_02

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018
Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …

News
shire_image_4

Shire announces split into two business units, downgrades revenue forecast

January 9, 2018
Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease

Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …

News
Alzheimer's brain

Amgen and Novartis partner on Alzheimer’s and migraine treatments

September 2, 2015
Research and Development Alzheimer's disease, Amgen, Novartis, migraine, neurology, neuroscience

Amgen and Novartis have announced a global collaboration to develop neuroscience treatments in Alzheimer’s disease and migraine.  The companies plan …

News
Mark Rus image

Working Life: Shire’s Mark Rus

November 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Working Life, mark rus, neuroscience

How did you find your way into your current role? After completing an MSc in Economics at the London School …

Feature
Pfizer image

Pfizer partners with MedGenesis on Parkinson’s

September 16, 2014
Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience

Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …

News

AZ sets up Alzheimer’s research collaborative

July 13, 2012
Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …

News
astrazeneca image

AstraZeneca buys neuroscience molecules

July 13, 2012
Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …

News

Lilly invests in UK research base

May 2, 2012
Research and Development Elil Lilly, Erl Wood, neuroscience

Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …

News
Eli Lilly & Company

Lilly prepares late-stage pipeline boost

July 1, 2011
Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology

Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …

News

Cerovive failure another blow for AstraZeneca

October 26, 2006
Research and Development, Sales and Marketing AstraZeneca, Cerovive, neuroscience

 A drug which had held out the promise of reducing the disabling effects of stroke on patients will be abandoned …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026